Veraxa Biotech AG (VRXA)

Currency in USD
4.48
-1.38(-23.55%)
Closed·
4.27-0.21(-4.60%)
·
Unusual trading volume
Trading near 52-week Low
VRXA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.205.30
52 wk Range
4.2027.36
Key Statistics
Prev. Close
5.86
Open
5.3
Day's Range
4.2-5.3
52 wk Range
4.2-27.36
Volume
744.6K
Average Volume (3m)
49.72K
1-Year Change
-56.7985%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VRXA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Veraxa Biotech AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

VRXA Income Statement

Compare VRXA to Peers and Sector

Metrics to compare
VRXA
Peers
Sector
Relationship
P/E Ratio
0.0x−2.8x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x1.9x2.6x
Price / LTM Sales
0.0x1.4x3.0x
Upside (Analyst Target)
0.0%34.5%58.6%
Fair Value Upside
Unlock16.8%10.2%Unlock

Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation. The company utilizes proprietary payloads and genetic code expansion technology to engineer and manufacture homogeneous, stable bioconjugates with defined drug-to-antibody ratios. It also licenses technology platforms to support the development of new therapeutic strategies. The company serves professional clients in the healthcare sector, including those in drug development, biologicals, diagnostics, instrumentation, and partners with research organizations and business partners in the life sciences industry. The company was founded in 2021 and is based in Heidelberg, Germany.

Industry
-
Sector
-

FAQ

What Is the Veraxa Biotech (VRXA) Stock Price Today?

The Veraxa Biotech stock price today is 4.48 USD.

What Stock Exchange Does Veraxa Biotech Trade On?

Veraxa Biotech is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Veraxa Biotech?

The stock symbol for Veraxa Biotech is "VRXA."

What Is the Veraxa Biotech Market Cap?

As of today, Veraxa Biotech market cap is 147.77M USD.

From a Technical Analysis Perspective, Is VRXA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Veraxa Biotech Stock Split?

Veraxa Biotech has split 0 times.

What is the current trading status of Veraxa Biotech (VRXA)?

As of Jun 18, 2026, Veraxa Biotech (VRXA) is trading at a price of 4.48 USD, with a previous close of 5.86 USD. The stock has fluctuated within a day range of 4.20 USD to 5.30 USD, while its 52-week range spans from 4.20 USD to 27.36 USD.

What Is the VRXA Premarket Price?

VRXA's last pre-market stock price is 5.48 USD. The pre-market share volume is 49,520.00, and the stock has decreased by -0.38, or -6.41%.

What Is the VRXA After Hours Price?

VRXA's last after hours stock price is 4.27 USD, the stock has decreased by -0.21, or -4.60%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.